Kintor Pharma says alopecia primary endpoint met

Kintor Pharma has announced results of a phase II clinical trial for its potential topical drug to treat adult female androgeneticalopecia.

Related Keywords

Peking ,Beijing ,China ,Kintor Pharma ,Jianzhong Zhang ,Kintor Pharmaceutical ,Department Of Dermatology ,University People Hospital ,Kintor Pharmaceutical Limited ,Peking University People ,Savin Scale ,